960MO Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC

• DOI: 10.1016/j.annonc.2021.08.1345
• Publication Date: 2021-09-21T19:04:02Z
• Authors: D.V. Catenacci; C-Y. Liao; S. Maron; B.J. Solomon; A. Mahipal; M.L. Johnson; D. Carbone; B.S. Henick; B. Johnson; S. Roychowdhury; K. Mody; D.H. Ahn; E. Bournazou; D. Schenk; S. Kounlavouth; L. Kraemer; G. Talbot; R. Rousseau; A.R. Ferguson; A. Spira
• Keywords: 0303 health sciences; 03 medical and health sciences